Result: Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial

Title:

Contributors:

Published:

Freiburg : Universität, 2023

Description:

1 Online-Ressource

Format:

E-Book

Language:

English

Notes:

Clinical cancer research. - 29, 4 (2023) , 805-814, ISSN: 1557-3265

DOI:

10.1158/1078-0432.ccr-22-1587

Additional information